Adherence of safety information on over‐the‐counter product labels and leaflets to the regulatory guidelines in Malaysia

Piyush Mittal, Xin Yi Gan, Ai Ying Sim, Jia Qi Yeo, Jia Xin Cheng, Suresh Shanmugham, Syed Shahzad Hasan

Research output: Contribution to journalArticle

Abstract

Aim
To evaluate the adherence of medication safety information provided on over‐the‐counter (OTC) product labels and patient information leaflets (PILs) to the Malaysian and international regulatory guidelines.

Methods
A total of 133 randomly sampled OTC medications (gastrointestinal = 31, pain = 36, skin = 35, coughs and colds = 31) from 17 community pharmacies located around Klang Valley, Malaysia were evaluated. The adherence of relevant safety information provided on the OTC product labels and PILs from the manufacturing companies to the Malaysian and international regulatory guidelines was evaluated.

Results
The majority of the products (n = 81) were locally manufactured, followed by 34 products from the European region. About 31% (n = 41) of the sampled OTC products were sold without PILs. Overall, 98% of the labels adhered to all the criteria, but none of the PILs adhered to all the parameters. Information on action to be taken in the case of a missed dose (96%), advice on consulting a doctor/pharmacist for further information (92%) and disposal instructions (98%) were generally missing. Surprisingly, none of the PILs included the compulsory statement which is essential for adverse drug reaction reporting. In addition, only 30% of the studied PILs provided information on the date of revision. Overall, imported products had slightly better adherence compared to locally manufactured products.

Conclusion
The safety information stated on the OTC products marketed in Malaysia has room for improvement to ensure safe and effective use of these products. A uniform format and collective effort is needed to ensure consumers receive adequate information about OTC products.
LanguageEnglish
Pages204-211
Number of pages7
JournalJournal of Pharmacy Practice and Research
Volume48
Issue number3
Early online date15 Jun 2018
DOIs
Publication statusPublished - 30 Jun 2018

Fingerprint

Malaysia
Labels
Guidelines
Safety
Essential Drugs
Skin
Medication Adherence
Pharmacies
Drug-Related Side Effects and Adverse Reactions
Pharmacists
Cough
Industry
Pain

Cite this

Mittal, Piyush ; Gan, Xin Yi ; Sim, Ai Ying ; Yeo, Jia Qi ; Cheng, Jia Xin ; Shanmugham, Suresh ; Hasan, Syed Shahzad. / Adherence of safety information on over‐the‐counter product labels and leaflets to the regulatory guidelines in Malaysia. In: Journal of Pharmacy Practice and Research. 2018 ; Vol. 48, No. 3. pp. 204-211.
@article{275c571301664884b8f7654099ce58c5,
title = "Adherence of safety information on over‐the‐counter product labels and leaflets to the regulatory guidelines in Malaysia",
abstract = "AimTo evaluate the adherence of medication safety information provided on over‐the‐counter (OTC) product labels and patient information leaflets (PILs) to the Malaysian and international regulatory guidelines.MethodsA total of 133 randomly sampled OTC medications (gastrointestinal = 31, pain = 36, skin = 35, coughs and colds = 31) from 17 community pharmacies located around Klang Valley, Malaysia were evaluated. The adherence of relevant safety information provided on the OTC product labels and PILs from the manufacturing companies to the Malaysian and international regulatory guidelines was evaluated.ResultsThe majority of the products (n = 81) were locally manufactured, followed by 34 products from the European region. About 31{\%} (n = 41) of the sampled OTC products were sold without PILs. Overall, 98{\%} of the labels adhered to all the criteria, but none of the PILs adhered to all the parameters. Information on action to be taken in the case of a missed dose (96{\%}), advice on consulting a doctor/pharmacist for further information (92{\%}) and disposal instructions (98{\%}) were generally missing. Surprisingly, none of the PILs included the compulsory statement which is essential for adverse drug reaction reporting. In addition, only 30{\%} of the studied PILs provided information on the date of revision. Overall, imported products had slightly better adherence compared to locally manufactured products.ConclusionThe safety information stated on the OTC products marketed in Malaysia has room for improvement to ensure safe and effective use of these products. A uniform format and collective effort is needed to ensure consumers receive adequate information about OTC products.",
author = "Piyush Mittal and Gan, {Xin Yi} and Sim, {Ai Ying} and Yeo, {Jia Qi} and Cheng, {Jia Xin} and Suresh Shanmugham and Hasan, {Syed Shahzad}",
year = "2018",
month = "6",
day = "30",
doi = "10.1002/jppr.1351",
language = "English",
volume = "48",
pages = "204--211",
journal = "Journal of Pharmacy Practice and Research",
issn = "1445-937X",
publisher = "Society of Hospital Pharmacists of Australia",
number = "3",

}

Adherence of safety information on over‐the‐counter product labels and leaflets to the regulatory guidelines in Malaysia. / Mittal, Piyush; Gan, Xin Yi; Sim, Ai Ying; Yeo, Jia Qi; Cheng, Jia Xin; Shanmugham, Suresh; Hasan, Syed Shahzad.

In: Journal of Pharmacy Practice and Research, Vol. 48, No. 3, 30.06.2018, p. 204-211.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adherence of safety information on over‐the‐counter product labels and leaflets to the regulatory guidelines in Malaysia

AU - Mittal,Piyush

AU - Gan,Xin Yi

AU - Sim,Ai Ying

AU - Yeo,Jia Qi

AU - Cheng,Jia Xin

AU - Shanmugham,Suresh

AU - Hasan,Syed Shahzad

PY - 2018/6/30

Y1 - 2018/6/30

N2 - AimTo evaluate the adherence of medication safety information provided on over‐the‐counter (OTC) product labels and patient information leaflets (PILs) to the Malaysian and international regulatory guidelines.MethodsA total of 133 randomly sampled OTC medications (gastrointestinal = 31, pain = 36, skin = 35, coughs and colds = 31) from 17 community pharmacies located around Klang Valley, Malaysia were evaluated. The adherence of relevant safety information provided on the OTC product labels and PILs from the manufacturing companies to the Malaysian and international regulatory guidelines was evaluated.ResultsThe majority of the products (n = 81) were locally manufactured, followed by 34 products from the European region. About 31% (n = 41) of the sampled OTC products were sold without PILs. Overall, 98% of the labels adhered to all the criteria, but none of the PILs adhered to all the parameters. Information on action to be taken in the case of a missed dose (96%), advice on consulting a doctor/pharmacist for further information (92%) and disposal instructions (98%) were generally missing. Surprisingly, none of the PILs included the compulsory statement which is essential for adverse drug reaction reporting. In addition, only 30% of the studied PILs provided information on the date of revision. Overall, imported products had slightly better adherence compared to locally manufactured products.ConclusionThe safety information stated on the OTC products marketed in Malaysia has room for improvement to ensure safe and effective use of these products. A uniform format and collective effort is needed to ensure consumers receive adequate information about OTC products.

AB - AimTo evaluate the adherence of medication safety information provided on over‐the‐counter (OTC) product labels and patient information leaflets (PILs) to the Malaysian and international regulatory guidelines.MethodsA total of 133 randomly sampled OTC medications (gastrointestinal = 31, pain = 36, skin = 35, coughs and colds = 31) from 17 community pharmacies located around Klang Valley, Malaysia were evaluated. The adherence of relevant safety information provided on the OTC product labels and PILs from the manufacturing companies to the Malaysian and international regulatory guidelines was evaluated.ResultsThe majority of the products (n = 81) were locally manufactured, followed by 34 products from the European region. About 31% (n = 41) of the sampled OTC products were sold without PILs. Overall, 98% of the labels adhered to all the criteria, but none of the PILs adhered to all the parameters. Information on action to be taken in the case of a missed dose (96%), advice on consulting a doctor/pharmacist for further information (92%) and disposal instructions (98%) were generally missing. Surprisingly, none of the PILs included the compulsory statement which is essential for adverse drug reaction reporting. In addition, only 30% of the studied PILs provided information on the date of revision. Overall, imported products had slightly better adherence compared to locally manufactured products.ConclusionThe safety information stated on the OTC products marketed in Malaysia has room for improvement to ensure safe and effective use of these products. A uniform format and collective effort is needed to ensure consumers receive adequate information about OTC products.

U2 - 10.1002/jppr.1351

DO - 10.1002/jppr.1351

M3 - Article

VL - 48

SP - 204

EP - 211

JO - Journal of Pharmacy Practice and Research

T2 - Journal of Pharmacy Practice and Research

JF - Journal of Pharmacy Practice and Research

SN - 1445-937X

IS - 3

ER -